Carregant...
A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion
BACKGROUND: The selective MAO-B inhibitor selegiline has been evaluated in clinical trials as a potential medication for the treatment of cocaine dependence. This study evaluated the safety of and pharmacologic interactions between 7 days of transdermal selegiline dosed with patches (Selegiline Tran...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2731040/ https://ncbi.nlm.nih.gov/pubmed/19646280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-9-13 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|